Apella Capital LLC Trims Stock Holdings in Doximity, Inc. $DOCS

Key Points

• Apella Capital LLC reduced its stake in Doximity, Inc. by 11.6% in the second quarter, holding 69,874 shares worth approximately $4.25 million after selling 9,165 shares.
• Doximity's recent earnings report showed an EPS of $0.36, surpassing estimates and marking a 15.2% year-over-year revenue increase.
• A number of analysts have raised their price targets for Doximity, with an average target of $67.00 and a consensus rating classified as Moderate Buy.

Apella Capital LLC cut its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 11.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,874 shares of the company's stock after selling 9,165 shares during the period. Apella Capital LLC's holdings in Doximity were worth $4,253,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Amalgamated Bank boosted its stake in Doximity by 0.3% during the 1st quarter. Amalgamated Bank now owns 60,928 shares of the company's stock worth $3,536,000 after purchasing an additional 186 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Doximity by 0.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company's stock worth $2,262,000 after buying an additional 210 shares during the period. Greenleaf Trust grew its holdings in shares of Doximity by 5.4% during the first quarter. Greenleaf Trust now owns 4,492 shares of the company's stock worth $261,000 after buying an additional 230 shares during the last quarter. Spire Wealth Management grew its holdings in shares of Doximity by 73.2% during the first quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after buying an additional 260 shares during the last quarter. Finally, Allworth Financial LP increased its position in Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after acquiring an additional 287 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Price Performance

Doximity stock opened at $71.05 on Monday. The stock's 50 day moving average price is $63.60 and its 200 day moving average price is $59.77. Doximity, Inc. has a 1-year low of $38.30 and a 1-year high of $85.21. The company has a market cap of $13.31 billion, a PE ratio of 71.05, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.Doximity's revenue for the quarter was up 15.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, equities research analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have weighed in on DOCS shares. Canaccord Genuity Group increased their price objective on Doximity from $50.00 to $59.00 and gave the stock a "hold" rating in a research report on Friday, August 8th. Truist Financial upped their price target on Doximity from $52.00 to $61.00 and gave the stock a "hold" rating in a research note on Thursday, July 17th. Piper Sandler increased their price target on Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a report on Monday, August 11th. Needham & Company LLC lifted their price objective on shares of Doximity from $67.00 to $75.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Finally, Robert W. Baird upped their price objective on shares of Doximity from $75.00 to $80.00 and gave the stock an "outperform" rating in a research report on Thursday. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $67.00.

Insider Activity at Doximity

In related news, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $57.09, for a total transaction of $114,180.00. Following the sale, the director owned 16,618 shares of the company's stock, valued at approximately $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Regina M. Benjamin sold 5,000 shares of the stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $63.00, for a total transaction of $315,000.00. Following the completion of the transaction, the director directly owned 16,618 shares of the company's stock, valued at approximately $1,046,934. This trade represents a 23.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 32,000 shares of company stock worth $1,929,380 over the last 90 days. Company insiders own 31.30% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.